Pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. American Society of Anesthesiologists (ASA) classification I-II 2. Age range of 18-65 years old, body mass index (BMI) 18-24kg/m2 3. All participants voluntarily participated in this study and signed informed consent
Exclusion criteria
Exclusion criteria: 1. Severe central or peripheral nervous system diseases; Severe respiratory or circulatory system diseases 2. Patients who have been taking anticoagulant drugs for a long time and have abnormal coagulation function; Patients with contraindications for nerve block such as infection and rash at the puncture site 3. History of allergies to relevant drugs 4. History of chronic pain, those who have used sedatives and analgesics within 24 hours before surgery 5. History of drug use, alcohol abuse, and substance abuse 6. Refusal to participate or inability to cooperate with the researcher in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analog Scale (VAS); | — |
Secondary
| Measure | Time frame |
|---|---|
| The dosage of sufentanil;Effective pressing frequency of analgesic pump;Number of times of remedial analgesia;Tumor necrosis factor alpha;Interleukin-26;T cell subpopulation (CD3+CD4+CD8+);Natural Killer Cells (NK); | — |
Countries
China
Contacts
The General Hospital of Western Theater Command